International Pharmaceutical Industry (IPI) is a peer-reviewed journal that offers the pharmaceutical and biopharmaceutical industry comprehensive coverage of important scientific, technology, regulatory, and business topics. The publication is read worldwide by professionals who manage outsourcing in this sector.
Over the past 15-20 years, the market for parenteral drug-device combination products has changed significantly, with innovation happening in both formulation and device design. Several factors have driven this shift, such as the rise of biologics and biosimilars, changes in healthcare systems needing cost-effective treatments, the increase in self-administration, and a greater emphasis on patient and user experience.
To read the full article visit p38-39